Approval · Notice of Compliance 2414 · 2001
ALKERAN: Notice of Compliance 2414
Issued August 28, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2414
- Date
- August 28, 2001
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer name
- Therapeutic class
- Antineoplastic (alkylating) agent
Products in this notice
Medicinal ingredients
- BUFFER SOLUTION 10 ML per VIAL
- MELPHALAN HCL 50 MG per VIAL
- MELPHALAN 2 MG per TAB